Marijuana stocks aren’t all alike. Take OrganiGram Holdings (NASDAQ:OGI) and Green Thumb Industries (OTC:GTBIF). OrganiGram’s share price is down more than 50% year to date with continued uncertainty for its business. Green Thumb’s stock has more than doubled so far in 2020 with seemingly bright prospects ahead.
Is going with Green Thumb over OrganiGram a slam dunk? Not necessarily. Here’s how the two pot stocks compare.
The case for OrganiGram
My Motley Fool colleague Sean Williams thinks that OrganiGram ranks as the Canadian pot stock that’s best positioned for long-term success. There are several reasons why Sean might be right.
OrganiGram is one of only a handful of cannabis producers that markets to all 10 Canadian provinces. The company launched its first value brand in the summer, giving it room to run in one of the country’s fastest-growing cannabis markets.
Speaking of fast-growing cannabis markets, OrganiGram appears to be in great shape in Canada’s “Rec 2.0” cannabis derivatives market. Its product lineup includes cannabis-infused chocolates and powdered beverage mixes.
In addition, the company has a promising international opportunity with its multiyear deal to supply dried cannabis flower to Canndoc, one of the top medical cannabis producers in Israel. OrganiGram will supply up to 6,000 kilograms of dried flower to Canndoc, with a purchase of 3,000 kilograms guaranteed by Dec. 31, 2021.
OrganiGram claims at least a couple